BRCA1 and breast carcinoma: To address this gap, we examined frequency and predictors of BRCA1/2 and multigene panel testing and assessed racial/ethnic differences in genetic testing frequency and results (pathogenic/likely pathogenic [P/LP], VUS, negative) among diverse women with early-onset breast cancer.